IndiaMTF — home
Stock

Aurobindo Pharma — MTF Book

AUROPHARMA · Aurobindo Pharma Limited
Health Technology

Daily Margin Trading Facility book for Aurobindo Pharma across NSE and BSE, from 01 Aug 2017. All figures in ₹ crore, derived from exchange public disclosures.

What is Aurobindo Pharma’s MTF book?

Aurobindo Pharma Limited (AUROPHARMA) has ₹50 crore funded under Margin Trading Facility across NSE and BSE as of 23 Oct 2026 — 0.03% of India’s MTF book, ranking #639. Over 1M (the last 30 trading days) the funded value has risen 0.6%, with the number of shares under margin down 0.3%.

Funded value
₹50 Cr
as of 23 Oct 2026
Rank in book
#639
2,141 days tracked
Share of book
0.03%
of the whole NSE + BSE book
Peak funded
₹361 Cr
on 03 Aug 2017
Largest single-day addition
+₹359 Cr
on 03 Aug 2017
Largest single-day unwind
−₹359 Cr
on 04 Aug 2017
Free-float market cap
₹43,516 Cr
full market cap ₹90,432 Cr · 48.1% free float · Mid cap
MTF share of free float
0.12%
0.3× the median mid cap · 0.1× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

0.02%0.20%0.38%0.56%Feb 2024Oct 2026
View as table: share of free float on margin30 months
Month-end% of free float
23 Oct 20260.122%
30 Sep 20260.124%
31 Aug 20260.120%
31 Jul 20260.163%
30 Jun 20260.117%
29 May 20260.178%
30 Apr 20260.169%
30 Mar 20260.165%
27 Feb 20260.205%
30 Jan 20260.188%
31 Dec 20250.189%
28 Nov 20250.182%
31 Oct 20250.274%
30 Sep 20250.305%
29 Aug 20250.498%
31 Jul 20250.382%
30 Jun 20250.428%
30 May 20250.340%
30 Apr 20250.206%
28 Mar 20250.188%
28 Feb 20250.187%
31 Jan 20250.190%
31 Dec 20240.149%
29 Nov 20240.112%
18 Jul 2024†0.089%
28 Jun 20240.139%
28 May 2024†0.082%
30 Apr 20240.094%
28 Mar 20240.170%
29 Feb 20240.220%

† Not the month’s last trading day: the last day the stock was in the archive that month (before 11 Nov 2025 the archive kept only the 500 largest positions).

Dated events

NSE & BSE split

How AUROPHARMA’s funded book divides across the two exchanges, as of 23 Oct 2026.
NSE
NSE ₹48 Cr · 95.6%BSE ₹2 Cr · 4.4%

MTF vs Price

Margin-funded outstanding for AUROPHARMA in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹1,571.70
as of 23 Oct 2026
Price, 1M
−7.5%
adjusted for splits and bonuses
Delivery, 20-day avg
54.0%
of traded volume actually settled
Sessions to unwind
1
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1D−₹0−0.2%+0.0%
+14
−2.4%building as it falls
10D+₹0+0.4%+0.7%
+2,440
−4.5%building as it falls
1M+₹0+0.6%−0.3%
−1,159
−7.1%unwinding as it falls
3M−₹14−21.6%−24.0%
−1,07,134
+3.2%unwinding into strength
6M−₹8−13.8%−26.6%
−1,22,575
+9.5%unwinding into strength
1Y−₹49−49.1%−60.3%
−5,15,778
+43.0%unwinding into strength

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where AUROPHARMA has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

AUROPHARMA — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
23 Oct 202650−₹00.03%639
22 Oct 202650−₹20.03%653
21 Oct 202652+₹40.03%642
19 Oct 202648+₹20.03%679
16 Oct 202646+₹20.03%700
15 Oct 202644−₹20.03%726
14 Oct 202646+₹20.03%703
13 Oct 202644−₹00.03%719
12 Oct 202644−₹00.03%718
09 Oct 202645−₹60.03%714
08 Oct 202650+₹00.03%656
07 Oct 202650+₹40.03%661
06 Oct 202646−₹50.03%692
05 Oct 202651−₹00.03%648
01 Oct 202651+₹00.03%648
30 Sep 202651+₹00.03%654
29 Sep 202651+₹10.03%654
28 Sep 202650+₹40.03%657
25 Sep 202647−₹10.03%692
24 Sep 202647−₹10.03%686
23 Sep 202648−₹60.03%675
22 Sep 202654+₹40.03%626
21 Sep 202649+₹10.03%659
18 Sep 202648−₹20.03%664
17 Sep 202650−₹20.03%655
16 Sep 202652−₹00.03%632
15 Sep 202653−₹10.03%634
11 Sep 202654+₹20.04%626
10 Sep 202652+₹20.03%645
09 Sep 202650—0.03%655

AUROPHARMA within Health Technology

Ranked #29 of 61 funded Health Technology stocks, carrying 0.8% of that sector’s margin book. Its 0.12% of free float on margin is 0.1× the sector median of 0.90%. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector% of free floatBook, 1M
27SUDEEPPHRMSudeep Pharma₹620.9%2.31%+16.3%
28MANKINDMankind Pharma₹580.9%0.21%−41.3%
29AUROPHARMAAurobindo Pharma₹500.8%0.12%+0.6%
30GLENMARKGlenmark Pharmaceuticals₹500.7%0.15%−2.5%
31SUPRIYASupriya Lifescience₹480.7%2.11%−1.6%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.